What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Disease
Internal medicine, Risk factor, Surgery, Epidemiology and Relative risk are his primary areas of study.
His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology, Endocrinology and Cardiology.
Gary D. Friedman combines subjects such as Cancer, Cohort study, Young adult, Prospective cohort study and Physiology with his study of Risk factor.
His work carried out in the field of Cancer brings together such families of science as Lung cancer, Helicobacter pylori and Cohort.
Gary D. Friedman interconnects Developed country, Disease and Gerontology in the investigation of issues within Epidemiology.
Gary D. Friedman focuses mostly in the field of Relative risk, narrowing it down to matters related to Breast cancer and, in some cases, Obstetrics, Gynecology, Menopause and Estrogen.
His most cited work include:
- Helicobacter pylori infection and the risk of gastric carcinoma. (3444 citations)
- Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer (2099 citations)
- Helicobacter pylori Infection and Gastric Lymphoma (1610 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Cancer, Surgery, Risk factor and Epidemiology.
His Internal medicine research incorporates elements of Oncology and Cardiology.
As a part of the same scientific study, Gary D. Friedman usually deals with the Cancer, concentrating on Incidence and frequently concerns with Disease.
His Odds ratio study deals with Case-control study intersecting with Endocrinology.
His Relative risk study combines topics from a wide range of disciplines, such as Breast cancer and Gynecology.
His Colorectal cancer research includes elements of Gastroenterology and Rectum.
He most often published in these fields:
- Internal medicine (65.43%)
- Cancer (24.38%)
- Surgery (20.68%)
What were the highlights of his more recent work (between 2008-2020)?
- Internal medicine (65.43%)
- Confidence interval (19.75%)
- Odds ratio (15.12%)
In recent papers he was focusing on the following fields of study:
Gary D. Friedman spends much of his time researching Internal medicine, Confidence interval, Odds ratio, Cancer and Case-control study.
In his study, Relative risk is inextricably linked to Surgery, which falls within the broad field of Internal medicine.
His Confidence interval research is multidisciplinary, relying on both Basal cell carcinoma, Cohort study and Confounding.
His work deals with themes such as Nifedipine, Atenolol, Liver cancer, Hydrochlorothiazide and Pharmacology, which intersect with Odds ratio.
His Cancer research includes themes of Lung cancer, Epidemiology and Cohort.
His Case-control study research is multidisciplinary, relying on both Body mass index, Endocrinology and Gynecology.
Between 2008 and 2020, his most popular works were:
- Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies (432 citations)
- Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence (122 citations)
- Hydrochlorothiazide use is strongly associated with risk of lip cancer (68 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Disease
His primary areas of study are Internal medicine, Odds ratio, Epidemiology, Cancer and Breast cancer.
The study of Internal medicine is intertwined with the study of Oncology in a number of ways.
His work deals with themes such as Endocrinology, Confidence interval, Cancer registry, Hydrochlorothiazide and Confounding, which intersect with Odds ratio.
His studies in Epidemiology integrate themes in fields like Pharmacy, Adverse effect and Proportional hazards model.
Gary D. Friedman combines subjects such as Cohort study and Pharmacology with his study of Cancer.
His Breast cancer study incorporates themes from Relative risk, Gynecology and Risk factor.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
